NCT01202799View on ClinicalTrials.gov

Pharmacokinetics, Bioavailability and Safety of PENNSAID® Gel

PHASE1CompletedINTERVENTIONAL

Enrollment

30

Participants

Timeline

Start Date

September 30, 2010

Primary Completion Date

November 30, 2010

Study Completion Date

November 30, 2010

Conditions

Pain

Interventions

DRUG

2% w/w diclofenac sodium topical gel

2% w/w diclofenac sodium topical gel

DRUG

1.5% w/w diclofenac sodium topical solution

1.5% w/w diclofenac sodium topical solution

DRUG

75 mg diclofenac sodium delayed release tablet

75 mg diclofenac sodium delayed release tablet

Trial Locations (1)

33025

Comprehensive Phase One, Miramar

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Mallinckrodt

INDUSTRY